TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
SDS Life Science AB
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
48,541
|
53,384
|
53,329 |
| Financial expenses |
0
|
447
|
934 |
| Earnings before taxes |
5,204
|
-2,272
|
-1,655 |
| EBITDA |
5,617
|
-1,301
|
-726 |
| Total assets |
26,248
|
18,893
|
20,165 |
| Current assets |
23,855
|
16,027
|
17,662 |
| Current liabilities |
10,215
|
8,636
|
8,904 |
| Equity capital |
5,837
|
1,793
|
703 |
| - share capital |
130
|
134
|
134 |
| Employees (average) |
42
|
50
|
45 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
22.2%
|
9.5%
|
3.5% |
| Turnover per employee |
1,156
|
1,068
|
1,185 |
| Profit as a percentage of turnover |
10.7%
|
-4.3%
|
-3.1% |
| Return on assets (ROA) |
19.8%
|
-9.7%
|
-3.6% |
| Current ratio |
233.5%
|
185.6%
|
198.4% |
| Return on equity (ROE) |
89.2%
|
-126.7%
|
-235.4% |
| Change turnover |
-3,077
|
-220
|
8,507 |
| Change turnover % |
-6%
|
0%
|
19% |
| Chg. No. of employees |
-8
|
5
|
11 |
| Chg. No. of employees % |
-16%
|
11%
|
32% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.